Immuno-metabolic modulation in cancer cachexia: novel therapeutic strategies to fight an old enemy
Type: dissertation
Abstract: Background: Cancer cachexia is a complex syndrome characterized by body weight loss and muscle wasting.It affects 50-80% of cancer patients, significantly reducing quality of life, anticancer treatment tolerance and efficacy, and survival rates, yet it lacks effective treatments.Multiple mechanisms are involved, including systemic inflammation, mitochondrial dysfunction, metabolic alterations, immune dysregulation, and oxidative stress.Previous studies showed that interleukin-4 (IL4) administration to tumor-bearing (TB) mice improves muscle mass and function, myogenesis, and survival.Additionally, IL4 and IL4 receptor are upregulated in the skeletal muscle in response to exercise.Objective: This study aimed to investigate the effects of IL4 on skeletal muscle and systemic metabolism, as well as its impact on the immune response in TB animals.Methods: C26 TB male mice were treated daily with IL4 by intraperitoneal injection.Muscle strength was assessed by grip strength test.The plasma was used to assess circulating cytokine and chemokine levels by bead-based multiplex assays.Immunophenotype analysis on isolated splenocytes was performed by flow cytometry.The tumor was analyzed by single nuclei RNA sequencing.The skeletal muscle was used to assess hexokinase II activity, mitochondrial proteins (western blotting) and respiration (high-resolution respirometry).Metabolomic and lipidomic analyses were performed on skeletal muscle and liver.Subsequently, C26 TB male mice were treated daily with febuxostat (FBX) by oral gavage.The skeletal muscle was used to assess ex vivo contractility and markers of inflammation, proteostasis and mitochondrial homeostasis (western blotting).Results: IL4 treatment counteracted the loss of body weight, muscle mass and strength in the C26 TB mice.Cancer-induced dysregulations in the circulating cytokine and chemokine profile were corrected as well, including a partial reduction towards control levels of IL6 and TNFα.In addition, IL4 improved the immune response in the C26 hosts, significantly counteracting cancer-induced systemic immunosuppression.Conversely, IL4 promoted an immunosuppressive tumor microenvironment (TME), increasing the proportion of M2 macrophages and malignant cells, despite comparable gross tumor mass between treated and untreated mice.As for the skeletal muscle, IL4 treatment in the C26 hosts improved energy metabolism, as shown by the improved hexokinase II activity, mitochondrial homeostasis and
Author: RUBINI, GIACOMO
Institution: University of Turin
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Cancer League of Colorado, Associazione Italiana per la Ricerca sul Cancro, Università degli Studi del Piemonte Orientale, Università degli Studi di Torino, National Institutes of Health, Cancer Center, University of Colorado, Anschutz Medical Campus, University of Colorado, National Cancer Institute
OpenAlex ID: W7217869253
